Explore how Medicube’s new kojic acid deodorant brightens underarms. Learn how it works, its benefits, and why this trend is changing skincare.

FDA clears UGN-501 IND for non-muscle invasive bladder cancer treatment. A new oncolytic virus therapy begins Phase 1 trials. Read about this promising approach.

Breakthrough T1D awards a grant to study SAB-142 for Stage 3 Type 1 Diabetes in the PRISE-hATG clinical trial. A potential new therapy is on the horizon.

New ultrasound wristbands capture human muscle movements to create robot training data. It’s a major leap for teaching humanoid robots to handle objects.

KFSH argues for real hospital provider transformation at HLTH Europe. It’s not just about new tech, but redesigning care pathways with real data.

AbbVie showcases new blood cancer research data at EHA 2026. Six oral presentations highlight advances in treatment for patients facing leukemia, lymphoma, and more.

Wegovy pill prescriptions surpass 3 million, reaching new patients every 5 seconds. See the data on GLP-1 obesity therapy’s record-breaking launch.

Henry Schein elects William K. Daniel as its new independent board chairman, succeeding Stanley Bergman after his 44-year tenure. See what this leadership change means.

A fatal surgical error liver removal highlights hospital safety failures. The surgeon said he ‘couldn’t tell the difference’ between organs. Read the shocking details.